Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.

Thorac Cancer · 2022 · PMC9376174 · PMID 35808895

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

adenocarcinoma immunotherapy non‐small cell lung cancer programmed death‐ligand 1 thyroid transcription factor‐1 Analysis of positive TTF‐1 expression rate by PD‐L1 expression level showed an increasing trend for the TTF‐1 positive rate as PD‐L1 TPS increased (Figure S1 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.